Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

S1P and the birth of platelets.
IL-1-induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation.
Type D, anxiety and depression in association with quality of life in patients with Parkinson's disease and patients with multiple sclerosis.
T1- vs. T2-based MRI measures of spinal cord volume in healthy subjects and patients with multiple sclerosis.
The re-emergence of antigen-specific tolerance as a potential therapy for MS.
The clinical relevance of force platform measures in multiple sclerosis: a review.
Multiple sclerosis in Germany: data analysis of administrative prevalence and healthcare delivery in the statutory health system.
Age-related Shift in Neural Complexity Related to Task Performance and Physical Activity.
[Two new oral disease modifying therapies in relapsing remitting multiple sclerosis].
The role of speed versus working memory in predicting learning new information in multiple sclerosis.
Unusual Manifestations of Pediatric Neuromyelitis Optica.
Demyelinating disorders secondary to TNF-inhibitor therapy for the treatment of psoriasis: A review.
African ancestry is a predictor factor to secondary progression in clinical course of multiple sclerosis.
CNS-wide Sexually Dimorphic Induction of the Major Histocompatibility Complex 1 Pathway With Aging.
Optic neuritis in neuromyelitis optica.
Alexithymia in Neurological Disease: A Review.
Regulation of Experimental Autoimmune Encephalomyelitis by TPL-2 Kinase.
Renal deterioration in multiple sclerosis patients with neurovesical dysfunction.
Bioinformatics Mining and Modeling Methods for the Identification of Disease Mechanisms in Neurodegenerative Disorders.
Burden of disease of multiple sclerosis in Korea.
Recombinant human PDCD5 (rhPDCD5) protein is protective in a mouse model of multiple sclerosis.
Cerebral vein changes in relapsing-remitting multiple sclerosis demonstrated by three-dimensional enhanced T (2) (*) -weighted angiography at 3.0 T.
Management of fingolimod-associated macular edema.
Cardiovascular effects of fingolimod: A review article.
Preserved Antigen-Specific Immune Response in Patients with Multiple Sclerosis Responding to IFNβ-Therapy.

Pages